Descripción del proyecto
Formación para una fabricación farmacéutica ecológica y digital
La industria farmacéutica europea se enfrenta al importante desafío de ecologizar y digitalizar sus procesos de fabricación. La escasez de ingenieros y científicos cualificados dificulta los progresos en este ámbito. En este contexto, el proyecto GreenDigiPharma, financiado con fondos europeos, producirá una cohorte de diez doctorados altamente cualificados y formados que liderarán la transformación ecológica y digital de la fabricación farmacéutica tanto en entornos académicos como industriales. El equipo del proyecto se centrará en problemas acuciantes de la fabricación sostenible y explorará métodos más ecológicos para fabricar productos farmacéuticos, incorporando tecnologías innovadoras como los nanocatalizadores heterogéneos y la biocatálisis, técnicas novedosas de purificación y herramientas de digitalización. El programa GreenDigiPharma también proporcionará a estos investigadores noveles conocimientos científicos y transferibles sobre derechos de propiedad intelectual, espíritu empresarial, gestión de datos e innovación.
Objetivo
Greening and digitalizing pharmaceutical manufacturing is one of the grand challenges of Europe's pharma-industry. It offers a significant opportunity to boost productivity, improve competitiveness and reduce the industry large environmental footprint. Current progress is impaired by shortage of trained engineers and scientists, who can design green and digital pharmaceutical processes.
This MSCA doctoral network will focus on addressing these skills gaps, delivering a cohort of highly-skilled and trained PhD graduates that will lead the green and digital transformation of the pharmaceutical manufacturing, both in academic and industrial environments. The consortium brings together 7 universities, 1 research center, and additional 11 associated members from academia and industry. This will address urgent topics in continuous green manufacturing and develop greener routes to prepare pharmaceutical products, promoting the adoption of novel technologies (flow synthesis instead batch methods, heterogeneous nano and biocatalysis in lieu of homogeneous catalysts, renewable carbon sources, novel purification methods, digitalization tools) for sustainable manufacturing.
Specific PhD topics for 10 ESRs have been outlined. The research and training programme will equip the ESRs with key scientific and transferable skills, such as IPR, entrepreneurship, data and innovation management. The consortium strong track record in the management of interdisciplinary research and training will ensure effective and timely training of the next-generation leaders of Europe’s pharma-industries. The exposure to academic and industry sectors will also provide the researchers with unparalleled career opportunities.
Ámbito científico
- natural scienceschemical sciencesorganic chemistry
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- engineering and technologyindustrial biotechnologybioprocessing technologies
- engineering and technologychemical engineeringchemical process engineering
- natural scienceschemical sciencescatalysisbiocatalysis
Palabras clave
Programa(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Régimen de financiación
HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral NetworksCoordinador
20133 Milano
Italia